Southpoint Capital Advisors LP
SEC Form 4 insider trading activity
Southpoint Capital Advisors LP has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Dec 29, 2025.
On the most recent filing, Southpoint Capital Advisors LP is listed as 10% Owner at FENNEC PHARMACEUTICALS INC. Inside the rolling window, Southpoint Capital Advisors LP reported no open-market purchases and 4 open-market sales totaling $9.7M in FENC. The largest disclosed transaction in the window is a sale of 1,000,000 FENC shares on Dec 24, 2025, worth $7.5M.
Companies traded
Other insiders at FENC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Southpoint Capital Advisors LP made?
Southpoint Capital Advisors LP has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Southpoint Capital Advisors LP trade?
Southpoint Capital Advisors LP has filed SEC Form 4 disclosures for 1 company, including FENC.
When was Southpoint Capital Advisors LP's most recent SEC Form 4 filing?
Southpoint Capital Advisors LP's most recent SEC Form 4 filing on Tracefour is dated Dec 29, 2025.
What is Southpoint Capital Advisors LP's total buy and sell value in the current window?
Inside the rolling retention window, Southpoint Capital Advisors LP bought $0 and sold $9.7M based on SEC Form 4 filings.
What was Southpoint Capital Advisors LP's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,000,000 FENC shares on 2025-12-24, worth $7.5M, per SEC Form 4 filings.